In Neuroendocrine Tumors (NETs), Notch expression is reduced, with concomitant mutations in Notch pathway components [144,145]; scientific evidence shows that Notch1 activation inhibits cell proliferation, indicating a tumor suppressive role [146]. This evidence concerns the gene NOTCH1 and neoplasm.